Search

everythinglearnresearchcommunity

for

Search:↓

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.

DPK-060 in poloxamer gel effectively treats skin infections, but nanocarriers don't enhance its efficacy.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Apremilast may help treat hair loss in alopecia areata.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Individualized treatments may help manage Dercum's disease symptoms.

DPCP can help regrow hair in some people with severe alopecia.

Applying a specific inhibitor lightens skin and hair color.

More research is needed to understand if GLP-1 agonists affect hair health.

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

Finasteride helps improve treatment for benign prostatic hyperplasia.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Dendrobium officinale polysaccharide helps hair growth by activating the WNT signaling pathway.

Gp₄G promotes hair growth and improves skin health.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

DCP in isopropanol is better tolerated for treating alopecia areata.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

PP405 shows promise as a new, effective treatment for hair loss with minimal side effects.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.